Inventor
LEE SANG-KYOU
KR12 patents
⚠️ This page may combine multiple inventors who share the name “LEE SANG-KYOU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORHUMANTECH CO LTD
5 patentsUS7700109B2Apr 20, 2010
Biomolecule transduction motif Mph-1-BTM and the use thereof
FORHUMANTECH CO LTD2 citations59
US7981446B2Jul 19, 2011
Pharmaceutical compositions and methods for delivering nucleic acids into cells
FORHUMANTECH CO LTD3 citations58
US7902154B2Mar 8, 2011
Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same
FORHUMANTECH CO LTD3 citations56
US7354737B2Apr 8, 2008
Biomolecule transduction motif Sim-2-BTM and the use thereof
FORHUMANTECH CO LTD4 citations55
US7723299B2May 25, 2010
Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein
FORHUMANTECH CO LTD1 citations48
GOOD T CELLS INC
4 patentsUS11091538B2Aug 17, 2021
Use of regulatory T cell-specific surface protein LRIG-1
GOOD T CELLS INC2 citations70
US11932686B2Mar 19, 2024
Use of regulatory T cell-specific surface protein LRIG-1
GOOD T CELLS INC0 citations60
US11414467B2Aug 16, 2022
Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof
GOOD T CELLS INC0 citations60
US10494411B2Dec 3, 2019
Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof
GOOD T CELLS INC0 citations50
LEE SANG KYOU
2 patentsUS11655287B2May 23, 2023
Use of regulatory T cell-specific surface protein LRIG-1
LEE SANG KYOU1 citations67
US10544196B2Jan 28, 2020
Composition containing SMAD protein for treatment of autoimmune diseases, a fusion protein comprising SMAD protein, an expression vector and a method for preparing the same
LEE SANG KYOU0 citations44